U.S. market Closed. Opens in 1 day 3 hours 26 minutes

VOR | Vor Biopharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue3.49M8.96M4.45M1.39M91.00K20.00K
Gross Profit-3.49M-8.96M-4.45M-1.39M-91.00K-20.00K
Operating Expenses126.04M93.42M69.02M43.37M10.42M2.86M
Selling, General & Admin31.72M28.87M21.49M11.75M4.22M427.00K
Research & Development94.31M64.55M47.53M31.62M6.20M2.43M
Other Operating ExpensesN/AN/AN/AN/AN/AN/A
Operating Income-126.04M-93.42M-69.02M-43.37M-10.42M-2.86M
Other Expenses / Income8.17M1.32M119.00K29.00K-422.00K-1.29M
Before Tax Income-117.86M-92.09M-68.90M-43.34M-10.84M-4.15M
Income Tax ExpensesN/A-1.32M-119.00K427.70K608.00K-289.00K
Net Income-117.86M-90.77M-68.78M-43.34M-11.45M-4.15M
Interest ExpensesN/AN/AN/AN/A608.00K1.00M
Basic Shares Outstanding67.19M39.55M37.17M37.13M37.12M5.66M
Diluted Shares Outstanding67.19M39.55M37.17M37.13M37.12M5.66M
EBITDA-114.37M-90.89M-67.58M-41.95M-10.17M-2.84M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-117.86M-92.09M-68.90M-42.91M-10.23M-3.44M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙